Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?

Purpose: Somatostatin is a peptide with a potent and broad antisecretory action, which makes it an invaluable drug target for the pharmacological management of pituitary adenomas and neuroendocrine tumors. Furthermore, somatostatin (SST) receptors (SSTR1, 2A and B, 3, 4 and 5) belong to the G protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Domvri, Kalliopi, Bougiouklis, Dimitrios, Zarogoulidis, Paul, Porpodis, Konstantinos, Xristoforidis, Manolis, Liaka, Alexandra, Eleutheriadou, Ellada, Lampaki, Sofia, Lazaridis, George, Organtzis, John, Kyriazis, George, Hohenforst-Schmidt, Wolfgang, Tsirgogianni, Katerina, Karavasilis, Vasilis, Baka, Sofia, Darwiche, Kaid, Freitag, Lutz, Trakada, Georgia, Zarogoulidis, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349876/
https://www.ncbi.nlm.nih.gov/pubmed/25767606
http://dx.doi.org/10.7150/jca.11308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349876/
https://www.ncbi.nlm.nih.gov/pubmed/25767606
http://dx.doi.org/10.7150/jca.11308

Ejemplares similares